Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium ; volume:12 ; number:1 ; day:20 ; month:12 ; year:2022 ; pages:1-16 ; date:12.2022
Scientific reports ; 12, Heft 1 (20.12.2022), 1-16, 12.2022

Creator: Naser Al Deen, Nataly
Atallah Lanman, Nadia
Chittiboyina, Shirisha
Fostok, Sabreen
Nasr, Rihab
Lelièvre, Sophie
Talhouk, Rabih

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41598-022-25663-8

URN: urn:nbn:de:101:1-2023030221025922474538

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:52 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Naser Al Deen, Nataly
Atallah Lanman, Nadia
Chittiboyina, Shirisha
Fostok, Sabreen
Nasr, Rihab
Lelièvre, Sophie
Talhouk, Rabih
SpringerLink (Online service)

Other Objects (12)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer

Graffiti | Streetart

miR

Graffiti | Streetart

MiR

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Graffiti | Streetart

Zu MiR

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms

Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer

Graffiti | Streetart

miR

Graffiti | Streetart

MiR

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Graffiti | Streetart

Zu MiR

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms

Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer

Graffiti | Streetart

miR

Graffiti | Streetart

MiR

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Graffiti | Streetart

Zu MiR

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms

Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer

miR

MiR

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Zu MiR

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms

Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer

miR

MiR

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Zu MiR

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms

Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom

Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer

miR

MiR

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Zu MiR

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms

Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom

Related objects

Reset password